In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Editorial - February 2019

ESC Working Group on Cardiovascular Regenerative and Reparative Medicine news

Gene Therapy, Cell Therapy
ESC Working Groups

The Mission of the ESC Working Group on Cardiovascular Regenerative and Reparative Medicine (CARE) is to improve our knowledge and to develop therapies in this field through the synergy of basic discoveries and translational clinical efforts from dedicated centres all around the world.

In order to achieve this mission, last November the working group CARE organized a Science Retreat Meeting held on 29-30 November at the European Heart Agency of Brussels.

This year 2019, the retreat was focus on three main topics:

  • Workshop 1. Emerging and classical products for cardiovascular repair
  • Workshop 2. Preclinical models on cardiovascular regenerative medicine
  • Workshop 3. Opportunity, design, regulation and funding of clinical trials

The retreat will be joined by Working Group nucleus members and 9 invited key leaders of the different areas of knowledge. Conclusions of the retreat will be published in the next months and presented in the next endorsed meeting of the working group:

Next 9-10 May will be held in Madrid the 16th International Symposium on Cardiovascular Regeneration and Repair.  This meeting will put together the important milestones achieved since the last edition of the symposium. Recent controversies from basic science, as well as confusing clinical results, have produced a kind of uncertainty and scepticism among general public, scientists, physicians, decision makers, biotech industry and investors. So, it is now more important than ever to objectively discuss lights and shadows and future of cardiac regenerative and reparative medicine in an open session.